• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

III-IV期口咽鳞状细胞癌患者的影像学检查方式使用趋势

Imaging modality utilization trends in patients with stage III-IV oropharyngeal squamous cell carcinoma.

作者信息

Ichimiya Yukako, Alluri Krishna, Marcus Charles, Best Simon, Chung Christine H, Subramaniam Rathan M

机构信息

Russell H Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University Baltimore, MD.

Department of Otolaryngology and Head and Neck Surgery, Johns Hopkins University Baltimore, MD.

出版信息

Am J Nucl Med Mol Imaging. 2015 Jan 15;5(2):154-61. eCollection 2015.

PMID:25973336
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4396006/
Abstract

The objective of this study is to establish the utilization trends of CT, MRI, and FDG-PET/CT for evaluation of oropharyngeal squamous cell carcinoma (OPSCC) patients. A total of 173 patients with newly diagnosed stage III or IV OPSCC between 2003 and 2009 were included. Frequency of imaging modality use, divided into four time periods (2003-04, 2005-06, 2007-08 and 2009), was evaluated. For initial staging, percentage of PET/CT use was 64.6%, 87.5%, 94.1% and 96.3%, with an increasing trend (p < 0.001). The CT (p = 0.762) and MRI (p = 0.224) use demonstrated no change in trend. For post-treatment imaging, percentage of PET/CT use was 59.5%, 68.6%, 89.7% and 100%, with an increasing trend (p < 0.001). The CT use demonstrated a decreasing trend (p = 0.004) and MRI showed no trend change (p = 0.231). PET/CT is used with an increasing trend for initial staging and has become a central imaging modality for follow up evaluation after treatment, for advanced OPSCC.

摘要

本研究的目的是确定CT、MRI和FDG-PET/CT在评估口咽鳞状细胞癌(OPSCC)患者中的使用趋势。纳入了2003年至2009年间共173例新诊断为III期或IV期OPSCC的患者。评估了分为四个时间段(2003 - 04年、2005 - 06年、2007 - 08年和2009年)的成像模态使用频率。对于初始分期,PET/CT的使用百分比分别为64.6%、87.5%、94.1%和96.3%,呈上升趋势(p < 0.001)。CT(p = 0.762)和MRI(p = 0.224)的使用未显示趋势变化。对于治疗后成像,PET/CT的使用百分比分别为59.5%、68.6%、89.7%和100%,呈上升趋势(p < 0.001)。CT的使用呈下降趋势(p = 0.004),而MRI未显示趋势变化(p = 0.231)。PET/CT在初始分期中的使用呈上升趋势,并且已成为晚期OPSCC治疗后随访评估的核心成像模态。

相似文献

1
Imaging modality utilization trends in patients with stage III-IV oropharyngeal squamous cell carcinoma.III-IV期口咽鳞状细胞癌患者的影像学检查方式使用趋势
Am J Nucl Med Mol Imaging. 2015 Jan 15;5(2):154-61. eCollection 2015.
2
Planned neck dissection after chemoradiotherapy in advanced oropharyngeal squamous cell cancer: the role of US, MRI and FDG-PET/TC scans to assess residual neck disease.晚期口咽鳞状细胞癌放化疗后计划性颈清扫术:超声、磁共振成像及氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描在评估颈部残留病灶中的作用
J Craniomaxillofac Surg. 2014 Dec;42(8):1834-9. doi: 10.1016/j.jcms.2014.06.023. Epub 2014 Jul 9.
3
Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.标准化摄取值和代谢肿瘤体积在¹⁸F-FDG PET/CT上对口咽鳞状细胞癌的预后意义
Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1353-61. doi: 10.1007/s00259-015-3051-4. Epub 2015 Jun 12.
4
Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma.预处理 18F-FDG PET/CT 图像的纹理特征:在晚期 T 分期口咽鳞状细胞癌患者中的预后意义。
J Nucl Med. 2013 Oct;54(10):1703-9. doi: 10.2967/jnumed.112.119289. Epub 2013 Sep 16.
5
Is there an additive value of 18 F-FDG PET-CT to CT/MRI for detecting nodal metastasis in oropharyngeal squamous cell carcinoma patients with palpably negative neck?对于颈部触诊阴性的口咽鳞状细胞癌患者,18 F-FDG PET-CT相对于CT/MRI在检测淋巴结转移方面是否具有附加价值?
Acta Radiol. 2016 Nov;57(11):1352-1359. doi: 10.1177/0284185115587544. Epub 2016 Jul 19.
6
Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.头颈部鳞状细胞癌的局部区域肿瘤评估:MRI、PET/CT与PET/MRI一体化成像的比较
Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):92-102. doi: 10.1007/s00259-015-3145-z. Epub 2015 Aug 6.
7
The value of follow-up FDG-PET/CT in the management and prognosis of patients with HPV-positive oropharyngeal squamous cell carcinoma.随访氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)在人乳头瘤病毒(HPV)阳性口咽鳞状细胞癌患者管理及预后评估中的价值
J Med Imaging Radiat Oncol. 2015 Dec;59(6):681-6. doi: 10.1111/1754-9485.12354. Epub 2015 Sep 7.
8
Use of 18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography for Patient Management and Outcome in Oropharyngeal Squamous Cell Carcinoma: A Review.18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在口咽鳞状细胞癌患者管理及预后评估中的应用:综述
JAMA Otolaryngol Head Neck Surg. 2016 Jan;142(1):79-85. doi: 10.1001/jamaoto.2015.2607.
9
Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study.口咽鳞状细胞癌患者治疗后18F-FDG-PET/CT与增强CT的比较:有效性对比研究
Nucl Med Commun. 2017 Mar;38(3):250-258. doi: 10.1097/MNM.0000000000000639.
10
Intraindividual homogeneity of F-FDG PET/CT parameters in HPV-positive OPSCC.HPV 阳性口咽鳞癌 F-FDG PET/CT 参数的个体内同质性。
Oral Oncol. 2017 Oct;73:166-171. doi: 10.1016/j.oraloncology.2017.08.019. Epub 2017 Sep 14.

引用本文的文献

1
Impact of PET/CT on Staging and Treatment of Advanced Head and Neck Squamous Cell Carcinoma.PET/CT 对晚期头颈部鳞状细胞癌分期和治疗的影响。
Otolaryngol Head Neck Surg. 2019 Feb;160(2):261-266. doi: 10.1177/0194599818794479. Epub 2018 Aug 21.
2
Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study.口咽鳞状细胞癌患者治疗后18F-FDG-PET/CT与增强CT的比较:有效性对比研究
Nucl Med Commun. 2017 Mar;38(3):250-258. doi: 10.1097/MNM.0000000000000639.
3
Clinical Indications and Impact on Management: Fourth and Subsequent Posttherapy Follow-up F-FDG PET/CT Scans in Oncology Patients.临床指征及对治疗管理的影响:肿瘤患者治疗后第四次及后续的F-FDG PET/CT随访扫描
J Nucl Med. 2017 May;58(5):737-743. doi: 10.2967/jnumed.116.183111. Epub 2016 Nov 3.

本文引用的文献

1
PET/CT imaging and human papilloma virus-positive oropharyngeal squamous cell cancer: evolving clinical imaging paradigm.正电子发射断层扫描/计算机断层扫描成像与人类乳头状瘤病毒阳性口咽鳞癌:不断发展的临床影像学模式。
J Nucl Med. 2014 Mar;55(3):431-8. doi: 10.2967/jnumed.113.125542. Epub 2014 Jan 9.
2
FDG PET/CT imaging of oropharyngeal squamous cell carcinoma: characteristics of human papillomavirus-positive and -negative tumors.正电子发射断层扫描/计算机体层成像在口咽鳞癌中的应用:人乳头瘤病毒阳性和阴性肿瘤的特征。
Clin Nucl Med. 2014 Mar;39(3):225-31. doi: 10.1097/RLU.0000000000000255.
3
Addition of 18F-FDG PET/CT to clinical assessment predicts overall survival in HNSCC: a retrospective analysis with follow-up for 12 years.18F-FDG PET/CT 联合临床评估预测头颈部鳞癌患者的总生存期:一项 12 年随访的回顾性分析。
J Nucl Med. 2013 Dec;54(12):2039-45. doi: 10.2967/jnumed.113.121285. Epub 2013 Oct 7.
4
Impact of concurrent diagnostic level CT with PET/CT on the utilization of stand-alone CT and MRI in the management of head and neck cancer patients.同期诊断级 CT 联合 PET/CT 对头颈部癌症患者管理中独立 CT 和 MRI 应用的影响。
Clin Nucl Med. 2013 Oct;38(10):790-4. doi: 10.1097/RLU.0b013e31829f8ca5.
5
FDG PET/CT in the management of primary pleural tumors and pleural metastases.FDG PET/CT 在原发性胸膜肿瘤和胸膜转移瘤中的应用。
AJR Am J Roentgenol. 2013 Aug;201(2):W215-26. doi: 10.2214/AJR.13.10572.
6
The role of PET/CT in the management of cervical cancer.PET/CT 在宫颈癌管理中的作用。
AJR Am J Roentgenol. 2013 Aug;201(2):W192-205. doi: 10.2214/AJR.12.9830.
7
FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中的氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描成像生物标志物
Imaging Med. 2012 Dec;4(6):633-647. doi: 10.2217/iim.12.60.
8
PET/CT of cancer patients: part 1, pancreatic neoplasms.癌症患者的 PET/CT:第 1 部分,胰腺肿瘤。
AJR Am J Roentgenol. 2012 Nov;199(5):952-67. doi: 10.2214/AJR.11.8182.
9
Evidence-based guideline recommendations on the use of positron emission tomography imaging in head and neck cancer.基于证据的头颈部癌症正电子发射断层成像应用指南建议。
Clin Oncol (R Coll Radiol). 2013 Apr;25(4):e33-66. doi: 10.1016/j.clon.2012.08.007. Epub 2012 Sep 26.
10
The evolving role of positron emission tomography-computed tomography in organ-preserving treatment of head and neck cancer.正电子发射断层扫描-计算机断层扫描在头颈部癌症保器官治疗中的不断演变的作用。
Semin Nucl Med. 2012 Sep;42(5):320-7. doi: 10.1053/j.semnuclmed.2012.04.005.